Search 177 catalogue identities by name or alias. Find recorded vendor packages, markets and cited reference notes in one place.
15 entries have a reviewed selection of primary sources. Other entries are marked as awaiting review. A source review covers the stated claims; it does not certify a vendor, a batch, clinical efficacy or suitability for human use.
Categories such as “Healing” and “Weight Loss” are catalogue navigation labels, not evidence of an effect or an approved use. Similar names can identify different compounds; source notes flag reviewed distinctions.
Aliases: 5-amino
5-Amino-1MQ is a catalogue entry whose compound-specific reference review has not yet been completed.
5-Amino-1MQ Capsules is a catalogue entry whose compound-specific reference review has not yet been completed.
ACE-031 is a catalogue entry whose compound-specific reference review has not yet been completed.
Acetic Acid 0.6% is a catalogue entry whose compound-specific reference review has not yet been completed.
Acetyl Hexapeptide-3 (Argireline) is a catalogue entry whose compound-specific reference review has not yet been completed.
Adalank Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Adamax is a catalogue entry whose compound-specific reference review has not yet been completed.
Adamax 1032 Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Adamax Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Adipotide is a catalogue entry whose compound-specific reference review has not yet been completed.
Agomelatine Powder is a catalogue entry whose compound-specific reference review has not yet been completed.
AHK-Cu is a catalogue entry whose compound-specific reference review has not yet been completed.
AHK-Cu Topical is a catalogue entry whose compound-specific reference review has not yet been completed.
AICAR is a catalogue entry whose compound-specific reference review has not yet been completed.
Andarine (S4) is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: aod
FDA describes AOD-9604 as a 16-amino-acid peptide comprising hGH residues 177–191 plus an N-terminal tyrosine. This modification is part of its identity, not an optional naming detail.
Aliases: cibinetide
ARA-290 is a catalogue entry whose compound-specific reference review has not yet been completed.
B7-33 is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: bac water
Bacteriostatic water is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: bpc
BPC-157 is a 15-amino-acid peptide studied in animal injury models. Published human observations also exist, but the small pilot reviewed here cannot establish general safety or clinical benefit.
BPC-157 / KPV Capsules is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
Aliases: wolverine · blend
BPC-157 / TB-500 is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
BPC-157 / TB-500 / MGF is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
BPC-157 / TB-500 Capsules is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
BPC-157 / TB-500 Spray is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
BPC-157 Capsules is a catalogue entry whose compound-specific reference review has not yet been completed.
BPC-157 Spray is a catalogue entry whose compound-specific reference review has not yet been completed.
Bronchogen is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: cagri
Cagrilintide is a catalogue entry whose compound-specific reference review has not yet been completed.
Aliases: cagrilintide semaglutide
CagriSema is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
Aliases: gw-501516
Cardarine is a catalogue entry whose compound-specific reference review has not yet been completed.
Cardiogen is a catalogue entry whose compound-specific reference review has not yet been completed.
Cartalax is a catalogue entry whose compound-specific reference review has not yet been completed.
Cerebrolysin is a catalogue entry whose compound-specific reference review has not yet been completed.
Chonluten is a catalogue entry whose compound-specific reference review has not yet been completed.
CJC-1295 with a Drug Affinity Complex (DAC) is a modified growth-hormone-releasing-hormone analogue. The long-acting compound in the cited human research binds circulating albumin.
Aliases: mod grf · cjc
FDA’s chemical review distinguishes a 29-amino-acid CJC-1295 free base from DAC-bearing forms. This catalogue entry separates the no-DAC label from the long-acting DAC compound.
CJC-1295 / Ipamorelin Nasal Spray is recorded as a blend in the catalogue. A review of the exact combination, ingredient amounts and formulation has not yet been completed.
Cortagen is a catalogue entry whose compound-specific reference review has not yet been completed.
Decapeptide-12 is a catalogue entry whose compound-specific reference review has not yet been completed.